You own five percent of a private company — shares you earned as an early employee or bought into years ago. The majority owners vote to sell the whole business for a price you are convinced is far too low, perhaps to a buyer they have a side arrangement with. Your five percent cannot block the deal. Do you just take the payout and swallow the loss? In nearly every state, no: you can refuse the deal price and force a court to determine the fair value of your shares instead. That power is called the appraisal right, or dissenters' right, and it is the minority shareholder's last line of defense against being cashed out cheap.
But the right is fragile in three ways that surprise first-time dissenters. It exists only for the corporate actions the statute lists. It survives only if you follow a sequence of written steps in order, starting before the vote. And it may already be gone — signed away years earlier in a drag-along clause you skimmed during a funding round. Here is how the right works, what it pays, and how to keep it.
What Appraisal Rights Actually Give You
An appraisal right lets a shareholder who opposes certain major transactions opt out of the deal consideration and be paid the fair value of the shares, set by a court if the shareholder and the corporation cannot agree. You do not block the transaction — the merger still closes, the sale still happens. You simply replace the price the deal offers you with a value you can contest.
The right is purely statutory: it exists only where the corporation's state law says it does, and only for the actions the statute lists. The typical triggers across states are mergers and consolidations, share exchanges, conversions from one entity form to another, a sale of all or substantially all of the company's assets that requires a shareholder vote, and certain amendments to the articles of incorporation that materially and adversely affect your class of shares. The exact list varies by state — Minnesota's sits in section 302A.471 of its Business Corporation Act, Delaware's in section 262 of the General Corporation Law — so the first question in any dissent is always whether your state's statute covers the transaction in front of you.
Note what the list usually does not include: ordinary business decisions, dividend policy, executive pay, or a down round that dilutes you without a covered transaction. Being unhappy with management is not a trigger. A covered corporate action you voted against is.
Which Deals Trigger the Right — and the Market-Out Exception
The most important trigger for most readers is the cash-out merger, including the squeeze-out. A squeeze-out is any transaction whose effect is to eliminate minority shareholders for cash: the majority merges the company into an acquisition vehicle and your shares convert into a cash payment, like it or not. Short-form mergers — where a parent that already owns nearly all of a subsidiary merges it out without a full shareholder vote — work the same way. Appraisal exists precisely for these moments, because your vote cannot protect you when the outcome is predetermined.
Public-company shareholders face an additional wrinkle called the market-out exception. The logic is that if your shares trade on a liquid market, you already have a remedy that private-company holders lack: sell into the market. Delaware therefore generally denies appraisal for shares listed on a national securities exchange, or held of record by more than 2,000 holders, when the merger consideration is itself publicly traded stock. You keep your liquidity either way, so the statute sees no need for a court valuation.
But the exception snaps back — appraisal returns — when the merger forces you to accept something other than liquid stock for your shares. A cash-out merger, where public shareholders are paid only cash, restores appraisal rights even for shareholders of listed companies. That exception matters enormously in private equity buyouts and going-private transactions, where the entire point is to eliminate public shareholders for a cash price. If your listed shares are being cashed out, check the market-out carve-outs before assuming you have no remedy.
The Procedure Is a Trap for the Casual
Here is the hard truth about appraisal: the substance of your claim barely matters if your procedure is sloppy. Every statute conditions the right on strict, sequential, written steps, and missing one — even by a day — ends the dissent. Courts enforce these requirements mechanically. The typical sequence runs like this:
- Written notice of dissent before the vote. When the corporation holds a shareholder meeting on the action, you must deliver written notice that you intend to dissent before the vote is taken. Silence followed by a complaint afterward is not dissent.
- Do not vote in favor. A shareholder who votes for the transaction, or consents to it in writing, generally cannot then demand appraisal of the same shares. Abstaining or voting against preserves the right; voting yes destroys it.
- Written demand for payment after the action. Once the transaction is approved, the corporation sends a notice stating where to send your demand. You must deliver a written demand for payment of fair value by the stated deadline — commonly 30 days — and often surrender or restrict transfer of your share certificates at the same time.
- Continuous holding. In Delaware, you must have held the shares when you made your demand and continuously through the merger's effective date. Selling midstream, even after demanding appraisal, forfeits the right.
- Petition the court if you cannot agree on price. If the corporation's offered payment is too low, either side can petition the designated court — Delaware's Court of Chancery, for example — to determine fair value. Delaware sets a 120-day window after the merger's effective date to commence that proceeding.
Two practical consequences follow. First, calendar every deadline the day you learn of the transaction, and send every notice in a form that proves delivery. Second, get counsel early: appraisal procedure is unforgiving, and the cost of a lawyer reviewing two letters is trivial next to the value of the right those letters preserve.
How Courts Set Fair Value
If your dissent is perfected and the parties cannot agree on price, a judge values your shares. Three features of that valuation favor the dissenter more than most people expect.
The valuation date excludes the deal itself. Fair value is measured immediately before the transaction takes effect, excluding any appreciation or depreciation in anticipation of the merger. The court values the company as a going concern on a standalone basis — what your shares were worth as a slice of the living business, not what a buyer paid for control and not what the stock did on rumor of the deal. Synergies the buyer expects to create belong to the buyer, not to your valuation.
There is no minority discount. This is the single most valuable feature of appraisal. On the open market, a five percent block of a private company sells at a steep discount: no control, no market, no leverage. In appraisal, courts value the entire company as a going concern and award you your proportionate interest — five percent of the whole-company value, with no discount for minority status and, in most states, none for lack of marketability either. The Model Business Corporation Act states the rule explicitly, and court after court has held that minority discounts are inappropriate under dissenters' rights statutes. The discount a buyer would demand from you privately is exactly what appraisal refuses to apply.
Courts weigh several methods. Judges commonly consider discounted cash flow analysis, comparable-company and comparable-transaction multiples, and — with growing weight in recent years — the deal price itself when the sale process was genuinely competitive, plus the unaffected market price for public companies. No single method controls; the court makes its own independent determination. Interest typically runs on the award from the merger's effective date until payment, which compensates you for the years a contested appraisal can take.
The Waiver Buried in Your Drag-Along Clause
Now the trap that catches sophisticated shareholders: you may have already waived appraisal rights years before the merger, in a stockholders' agreement you signed during a funding round. Venture-backed companies routinely include drag-along provisions that obligate minority holders to vote for an approved sale, refrain from dissenting, and expressly waive appraisal rights if the drag-along is invoked. The provisions exist so that a single holdout cannot block or tax an exit the preferred majority wants.
Are advance waivers enforceable? The Delaware Supreme Court has upheld them, reasoning that the corporation statute does not prohibit sophisticated and informed stockholders — represented by counsel, with bargaining power, receiving consideration — from voluntarily agreeing to waive appraisal rights in advance. The standard NVCA model voting agreement now includes an express appraisal waiver as part of its drag-along section. Lower courts have occasionally refused to enforce a waiver where the company invoked the drag-along sloppily, without following the agreement's own procedural requirements — but a properly drafted and properly invoked drag-along with an explicit waiver is enforceable against the stockholders who signed it.
The lesson is timing. Review your stockholders' agreement, voting agreement, and any investor rights agreement the moment an exit appears — not after the merger closes. If you signed an express appraisal waiver, a dissent will likely be dismissed, and your leverage lies elsewhere: in negotiating the price before the deal is signed, or in claims the waiver does not cover, such as fraud. And if you are signing a funding round today, understand that the drag-along section is where your future appraisal right goes to die; founders with leverage sometimes negotiate carve-outs or price floors there.
Appraisal Is Usually Your Only Remedy
One more feature surprises dissenters: in most states, appraisal is the exclusive remedy for objecting to the price of a covered transaction. You cannot skip the appraisal procedure and sue directors for breach of fiduciary duty simply because you think the price was too low — courts will tell you the statute gave you a remedy and you should have used it. Price claims go through appraisal, full stop.
The exclusivity has narrow exceptions, and they matter. Fraud, illegality, and ultra vires acts fall outside it: if the proxy statement lied about the company's value, or the transaction was never properly authorized, those claims survive alongside or instead of appraisal. Some states also preserve direct fiduciary-duty claims for conflicted controller transactions that fail entire-fairness review. But the baseline stands — a complaint that amounts to "the price was inadequate" belongs in appraisal, and a shareholder who lets the demand deadline pass usually has no second door back in.
That exclusivity is also why professional investors take appraisal seriously. Specialized funds buy shares after a merger is announced and pursue appraisal — a strategy called appraisal arbitrage — betting that the court's fair value will exceed the deal price by enough to cover years of litigation. You do not need to be a fund to learn the lesson: the statute treats appraisal as the remedy, so treat its deadlines as the most important dates in the transaction.
What to Do When a Deal Lands on Your Desk
If the majority announces a transaction you oppose, work through this checklist before the vote:
- Confirm the trigger. Identify the transaction type and check whether your state's statute grants appraisal for it. Confirm no exclusion removes your shares — market-out rules, post-record-date acquisitions, or cash distributions of asset-sale proceeds can all defeat the right.
- Pull every agreement you signed. Read the stockholders' agreement, voting agreement, and drag-along provisions for an appraisal waiver before you spend a dollar perfecting a dissent the company can dismiss.
- Calendar every deadline immediately. Pre-vote dissent notice, the vote itself, the post-closing demand window, the petition deadline. Send everything in writing with proof of delivery.
- Vote no or abstain — never yes. A vote in favor of the transaction waives appraisal for those shares.
- Get your own valuation early. The corporation's offer reflects its interests. An independent valuation tells you whether the gap justifies litigation, and it anchors any settlement discussion.
Finally, keep your cost-basis records clean, because an appraisal payout is sale proceeds for tax purposes: your taxable gain is the payout minus what you paid for the shares. Years-old employee stock purchases and multi-round investments are exactly the records that go missing. A plain-text ledger entry when the payout arrives keeps the math honest — for example, 500 shares bought at a basis of 80.00 and cashed out for 42,500.00:
2026-11-15 * "Merger payout for 500 shares of Acme Corp"
Assets:Checking 42,500.00 USD
Assets:Investments:Acme-Stock -500 ACME {80.00 USD}
Income:Capital-Gains -2,500.00 USDTrack each lot's purchase price the day you acquire the shares — the Beancount documentation covers inventory booking in detail — and the payout entry writes itself when the deal closes.
Your last useful step is the simplest: the day you hear about the deal, write down every deadline and pull every agreement. Appraisal rewards the shareholder who acts in writing and on time, and it forgives nothing else.
